← FDA DRUG APPROVALS

FDA NDA · NDA019530

UCEPHAN

Sponsor: B BRAUN

APPLICATION
NDA019530
TYPE
NDA
ORIGINAL APPROVAL
1987-12-23
LATEST ACTION
1987-12-23
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

UCEPHANDiscontinued
SODIUM BENZOATE 100MG/ML, SODIUM PHENYLACETATE 100MG/ML · SOLUTION · ORAL

Approval history

1987-12-23Type 1 - New Molecular Entity and Type 4 - New Combination · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →